Quality of Life and Psychosexual Adjustment After Prophylactic Oophorectomy for a Family History of Ovarian Cancer

Overview

Journal Fam Cancer

Publisher Springer

Specialty Oncology

Date 2003 Oct 24

PMID 14574171

Citations 30

Authors

L Elit

M J Esplen

K Butler

S Narod

Affiliations

Soon will be listed here.

Abstract

Objectives: 1) To evaluate a woman's satisfaction with the decision to have a prophylactic oophorectomy for family history of ovarian cancer. 2) To explore the potential costs related to surgery such a menopausal symptoms and satisfaction with sexual functioning.

Methods: Women who had undergone a prophylactic oophorectomy for a family history of ovarian cancer in Ontario were invited to participate. Forty women returned a package of questionnaires addressing demographic information, family history, decisional conflict, risk comprehension, menopause-specific quality of life, satisfaction with sexual function, and other psychosocial questionnaires.

Results: The mean age of respondents was 54.8 years. Perceived risk for developing ovarian cancer decreased significantly after surgery (p = 0.0001). Overall quality of life on the SF-36 Health Survey demonstrated a level consistent with emotional and physical wellbeing in the general population. The Menopause-Specific Quality of Life scores were reduced compared to women of similar age on all parameters: vasomotor symptoms, psychosocial support, physical status and sexual quality of life. Satisfaction with sexual functioning was moderately to extremely compromised in 42.1%-53.7% of women.

Conclusion: While this study shows that women who choose to have prophylactic oophorectomy for a family history of ovarian cancer have a good overall quality of life and significant decrease in risk perception as a result of surgery, they experience menopausal symptoms and compromised sexual functioning.

Citing Articles

Beyond the diagnosis: gender disparities in the social and emotional impact of cancer.

Praca M, Sousa F, Batista Candido E, Lamaita R, Wender M, Silva Filho A Rev Assoc Med Bras (1992). 2024; 70(suppl 1):e2024S115.

PMID: 38865535 PMC: 11164259. DOI: 10.1590/1806-9282.2024S115.

Theory-based behavior change intervention to increase uptake of risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 pathogenic variant: The PREVENT randomized controlled trial.

Metcalfe K, Pal T, Narod S, Armel S, Shickh S, Buckley K Cancer Med. 2023; 12(17):18246-18257.

PMID: 37602539 PMC: 10524042. DOI: 10.1002/cam4.6417.

Controversies and Open Questions in Management of Cancer-Free Carriers of Germline Pathogenic Variants in .

Bernstein-Molho R, Friedman E, Evron E Cancers (Basel). 2022; 14(19).

PMID: 36230512 PMC: 9559251. DOI: 10.3390/cancers14194592.

Cancer Anxiety Mediates the Association Between Satisfaction With Medical Communication and Psychological Quality of Life After Prophylactic Bilateral Salpingo-Oophorectomy.

Zarbo C, Brugnera A, Frigerio L, Celi C, Compare A, Dessi V Front Psychol. 2022; 13:840931.

PMID: 35356354 PMC: 8959915. DOI: 10.3389/fpsyg.2022.840931.

Effectiveness of a Multi-Dimensional Group Counseling Program Based on the GATHER Approach on the Quality of Life in Surgically Menopausal Women.

Moghadam F, Mahmoodi Z, Kabir K, Mirabi P, Yazdkhasti M J Menopausal Med. 2020; 25(3):130-141.

PMID: 32307938 PMC: 6952707. DOI: 10.6118/jmm.19200.

References

Lerman C, Schwartz M, Miller S, Daly M, Sands C, Rimer B . A randomized trial of breast cancer risk counseling: interacting effects of counseling, educational level, and coping style. Health Psychol. 1996; 15(2):75-83. DOI: 10.1037//0278-6133.15.2.75. View

Erlick Robinson G, Rosen B, Bradley L, Rockert W, Carr M, Cole D . Psychological impact of screening for familial ovarian cancer: reactions to initial assessment. Gynecol Oncol. 1997; 65(2):197-205. DOI: 10.1006/gyno.1997.4686. View

Hallowell N . A qualitative study of the information needs of high-risk women undergoing prophylactic oophorectomy. Psychooncology. 2001; 9(6):486-95. DOI: 10.1002/1099-1611(200011/12)9:6<486::aid-pon478>3.0.co;2-y. View

Hilditch J, Lewis J, Peter A, van Maris B, Ross A, Franssen E . A menopause-specific quality of life questionnaire: development and psychometric properties. Maturitas. 1996; 24(3):161-75. DOI: 10.1016/s0378-5122(96)82006-8. View

Watson M, Duvivier V, Wade Walsh M, Ashley S, Davidson J, Papaikonomou M . Family history of breast cancer: what do women understand and recall about their genetic risk?. J Med Genet. 1998; 35(9):731-8. PMC: 1051425. DOI: 10.1136/jmg.35.9.731. View

Schwartz M, Lerman C, Miller S, Daly M, Masny A . Coping disposition, perceived risk, and psychological distress among women at increased risk for ovarian cancer. Health Psychol. 1995; 14(3):232-5. DOI: 10.1037//0278-6133.14.3.232. View

Evans D, Blair V, Greenhalgh R, Hopwood P, Howell A . The impact of genetic counselling on risk perception in women with a family history of breast cancer. Br J Cancer. 1994; 70(5):934-8. PMC: 2033538. DOI: 10.1038/bjc.1994.423. View

Rebbeck T, Levin A, Eisen A, Snyder C, Watson P, Cannon-Albright L . Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. J Natl Cancer Inst. 1999; 91(17):1475-9. DOI: 10.1093/jnci/91.17.1475. View

OConnor A . Validation of a decisional conflict scale. Med Decis Making. 1995; 15(1):25-30. DOI: 10.1177/0272989X9501500105. View

10.

Brain K, Gray J, Norman P, France E, Anglim C, Barton G . Randomized trial of a specialist genetic assessment service for familial breast cancer. J Natl Cancer Inst. 2000; 92(16):1345-51. DOI: 10.1093/jnci/92.16.1345. View

11.

Blumel J, Castelo-Branco C, Binfa L, Gramegna G, Tacla X, Aracena B . Quality of life after the menopause: a population study. Maturitas. 2000; 34(1):17-23. DOI: 10.1016/s0378-5122(99)00081-x. View

12.

Ritvo P, Robinson G, Irvine J, Brown L, Murphy K, Stewart D . A longitudinal study of psychological adjustment to familial genetic risk assessment for ovarian cancer. Gynecol Oncol. 1999; 74(3):331-7. DOI: 10.1006/gyno.1999.5518. View

13.

Horowitz M, WILNER N, Alvarez W . Impact of Event Scale: a measure of subjective stress. Psychosom Med. 1979; 41(3):209-18. DOI: 10.1097/00006842-197905000-00004. View

14.

Davis S, Burger H . Clinical review 82: Androgens and the postmenopausal woman. J Clin Endocrinol Metab. 1996; 81(8):2759-63. DOI: 10.1210/jcem.81.8.8768824. View

15.

McHorney C, Ware Jr J, Lu J, Sherbourne C . The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care. 1994; 32(1):40-66. DOI: 10.1097/00005650-199401000-00004. View

16.

Esplen M, Toner B, Hunter J, Glendon G, Butler K, Field B . A group therapy approach to facilitate integration of risk information for women at risk for breast cancer. Can J Psychiatry. 1998; 43(4):375-80. DOI: 10.1177/070674379804300405. View

17.

Hilditch J, Lewis J, Ross A, Peter A, van Maris B, Franssen E . A comparison of the effects of oral conjugated equine estrogen and transdermal estradiol-17 beta combined with an oral progestin on quality of life in postmenopausal women. Maturitas. 1996; 24(3):177-84. DOI: 10.1016/s0378-5122(96)82007-x. View

18.

Struewing J, Watson P, Easton D, Ponder B, Lynch H, Tucker M . Prophylactic oophorectomy in inherited breast/ovarian cancer families. J Natl Cancer Inst Monogr. 1995; (17):33-5. View

19.

Durfy S, Bowen D, McTiernan A, Sporleder J, Burke W . Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington. Cancer Epidemiol Biomarkers Prev. 1999; 8(4 Pt 2):369-75. View

20.

Lerman C, Lustbader E, Rimer B, Daly M, Miller S, Sands C . Effects of individualized breast cancer risk counseling: a randomized trial. J Natl Cancer Inst. 1995; 87(4):286-92. DOI: 10.1093/jnci/87.4.286. View